Self-assembling recombinant papillomavirus capsid proteins
Recombinant papillomavirus capsid proteins that are capable of self assembly into capsomer structures and viral capsids that comprise conformational antigenic epitopes are provided. The capsomer structures and viral capsids, consisting of the capsid proteins that are expression products of a bovine, monkey or human papillomavirus L1 conformational coding sequence proteins, can be prepared as vaccines to induce a high titer neutralizing antibody response in vertebrate animals. The self assembling capsid proteins can also be used as elements of diagnostic immunoassay procedures for papillomavirus infection.
1. An isolated or purified genetic construct comprising a HPV16 L1 open reading frame (ORF) encoding a HPV 16 L1 having Aspartate at amino acid 202 instead of Histidine and a vector wherein the ORF is under the control of a promoter of the vector.
2. The isolated or purified genetic construct of claim 1 , wherein said vector is an insect cell vector and the ORF is under the control of a promoter that is active in insect cells.
3. The isolated or purified genetic construct of claim 2 , wherein said insect cell vector is a baculovirus vector.
4. The isolated or purified genetic construct of claim 3 , wherein said baculovirus vector is formed by cotransfecting a Sf-9 insect cell with recombinant baculovirus DNA and wild-type baculovirus DNA.
5. The isolated or purified genetic construct of claim 1 , wherein said vector is a yeast cell vector and the ORF is under the control of a promoter that is active in yeast cells.
6. The isolated or purified genetic construct of claim 1 , wherein said vector is a mammalian cell vector and the ORF is under the control of a promoter that is active in mammalian cells.
7. The isolated or purified genetic construct of claim 6 , wherein said mammalian cell vector is a vaccinia vector.
8. An isolated or purified genetic construct comprising a HPV16 L1 open reading frame (ORF) encoding a HPV16 L1 having Aspartate at amino acid 202 instead of Histidine and a vector wherein the ORF is under the control of a promoter of the vector, and further comprising a HPV16 L2 open reading frame (ORF) encoding a HPV16 L2.
9. The isolated or purified genetic construct of claim 8 , wherein said vector is an insect cell vector and the ORF is under the control of a promoter that is active in insect cells.
10. The isolated or purified genetic construct of claim 9 , wherein said insect cell vector is a baculovirus vector.
11. The isolated or purified genetic construct of claim 10 , wherein said baculovirus vector is formed by cotransfecting a Sf-9 insect cell with recombinant baculovirus DNA and wild-type baculovirus DNA.
12. The isolated or purified genetic construct of claim 8 , wherein said vector is a yeast cell vector and the ORF is under the control of a promoter that is active in yeast cells.
13. The isolated or purified genetic construct of claim 8 , wherein said vector is a mammalian cell vector and the ORF is under the control of a promoter that is active in mammalian cells.
14. The isolated or purified genetic construct of claim 13 , wherein said mammalian cell vector is a vaccinia vector.
15. A host cell in cell culture comprising the isolated or purified genetic construct of any of claims 1 to 14 .
16. An isolated or purified genetic construct comprising a papillomavirus open reading frame (ORF) encoding a capsid protein wherein said papillomavirus ORF consists essentially of a HPV16 L1 ORF encoding a HPV16 L1 having Aspartate at amino acid 202 instead of Histidine, and a vector, wherein the ORF is under the control of a promoter of the vector.
17. The isolated or purified genetic construct of claim 16 , wherein said vector is an insect cell vector and the ORF is under the control of a promoter that is active in insect cells.
18. The isolated or purified genetic construct of claim 17 , wherein said insect cell vector is a baculovirus vector.
19. The isolated or purified genetic construct of claim 18 , wherein said baculovirus vector is formed by cotransfecting a Sf-9 insect cell with recombinant baculovirus DNA and wild-type baculovirus DNA.
20. The isolated or purified genetic construct of claim 16 , wherein said vector is a yeast cell vector and the ORF is under the control of a promoter that is active in yeast cells.
21. The isolated or purified genetic construct of claim 16 , wherein said vector is a mammalian cell vector and the ORF is under the control of a promoter that is active in mammalian cells.
22. The isolated or purified genetic construct of claim 21 , wherein said mammalian cell vector is a vaccinia vector.
23. A host cell in cell culture comprising the isolated or purified genetic construct of any of claims 16 to 22 .